Viridian Therapeutics, Inc.\DE - COM (VRDN)

Q4 2020 13F Holders as of 12/31/2020

Type / Class
Equity / COM
Number of holders
2
Total Shares
229K
Shares change
+229K
Total reported value, excl. options
$3.77M
Value change
+$3.77M
Put/Call ratio
0
Number of buys
2
Number of sells
0
Price
$16.46
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.